Parirenyatwa Hospital   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Harare Zimbabwe (1890)

Organization Overview

First Clinical Trial
2007
NCT00834457
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Parirenyatwa Hospital | Parirenyatwa Hospital, Harare, Zimbabwe | UZ- Parirenyatwa CRS

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Candidiasis (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Adenosquamous (Phase 2)

HIV Infections (Phase 2)

Malnutrition (Phase 2)

Sarcoma (Phase 3)

Sarcoma, Kaposi (Phase 3)

Severe Acute Malnutrition (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 14